期刊文献+

CYP2C19基因多态性与维吾尔族冠心病相关性 被引量:6

Correlation between genetic polymorphism of cytochrome P4502C19 and coronary artery disease in Uygur patients
原文传递
导出
摘要 目的:探讨细胞色素P450(CYP)2C19基因多态性与新疆维吾尔族人群冠心病的相关性。方法:采用聚合酶链反应-限制性片段长度多态性方法,对234例冠心病患者(冠心病组)和132例健康受试者(对照组)CYP2C19基因rs6583954位点进行多态性分析。结果:CYP2C19基因rs6583954位点等位基因CT在冠心病组分别为84.83%和15.17%,在对照组分别为78.79%和21.21%,2组等位基因频率差异有统计学意义(P〈0.05);冠心病组CC基因型为73.1%,对照组为61.4%,2组比较差异有统计学意义(P=0.0201);Logistic回归分析显示在调整了年龄、性别、高血压、糖尿病、高胆固醇血症等传统危险因素之后,CYP2C19基因多态性仍是维吾尔族冠心病发生的重要危险因素,基因型CC:OR值=3.25,95%CI为0.73~14.36;基因型CT:OR值=1.59,95%CI为0.34~7.35。结论:CYP2C19基因多态性可增加维吾尔族吸烟者冠心病的发生风险。 Objective To investigate the correlation between the polymorphism of CYP2C19 gene and Uygur patients with coronary heart disease in Xinjiang.Methods The genotypes of the CYP2C19 SNP(rs6583954) were detected with the technique of polymerase chain reaction and analyzed with restriction fragment length polymorphism in 234 patients with coronary heart disease and 132 controls.Results The frequencies of CYP2C19 C and T alleles were 84.83% and 15.17% in coronary heart disease patients,and 78.79% and 21.21% in controls,which showed significant differences between two groups(P0.05).The frequency of CC was 73.1% in coronary heart disease patients,and 61.4% in controls,which showed a significant difference between two groups(P=0.0201).The CYP2C19 polymorphism was still the main risk factor for coronary heart disease in Uygur patients after adjusting the traditional risk factors such as sex,age,hypertension,diabetes mellitus,and hypercholesterolemia by Logistic analysis.The OR value of genotype CC was 3.25,and the 95%CI was 0.73 to 14.36.The OR value of genotype CT was 1.59,and the 95%CI was 0.34 to 7.35.Conclusion The genetic polymorphism of CYP2C19 may increase the risk for coronary artery disease in Uygur patients.
出处 《中华实用诊断与治疗杂志》 2010年第7期632-634,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 新疆维吾尔自治区重大专项基金(200733146-3)
关键词 冠心病 CYP2C19 基因多态性 维吾尔族 Coronary artery disease CYP2C19 genetic polymorphism Uygur
  • 相关文献

参考文献14

  • 1Sabatine M S, Seidman J G, Seidman C E. Cardiovascular genornics[J]. Circulation,2006,113(11) :450-455.
  • 2Seubert J M, Zeldin D C, Nithipatikom K, et al. Role of epoxyeicosatricnoic acids in protecting the myocardium following ischemia/reperfusion injury [ J]. Prostaglandings Other Lipid Mediat, 2007,82 (1-4) : 50-59.
  • 3Elbekai R H, E1-Kadi A O. Cytochrome P450 enzymes: central players in cardiovascular health and disease [J ]. Pharmacol Ther, 2006,112 (2) : 564-587.
  • 4周兵,吴开霞,李勇,周长高.236例冠状动脉造影患者临床背景资料分析[J].中华实用诊断与治疗杂志,2008,22(11):872-873. 被引量:8
  • 5Marenberg M E, Risch N, Berkman L F, et al. Genetic susceptibility to death from coronary heart disease in a study of twins[J]. N Engl J Med,1994,330(15) :1041-1046.
  • 6Hingorani A D. Endothelial nitric oxide synthase polymorphisms and hypertension[J]. Curr Hypertens Rep, 2003,5 (1) : 19-25.
  • 7Ikonomidis I, Andreotti F, Economou E. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin[J].Circulation, 1999, 100 (8) : 793-798.
  • 8Cooper C D, Solan J L, Dolejsi M K. Analysis of connexin phosphorylation sites[J]. Method, 2000,20 (2) : 196-204.
  • 9Bieche I, Narjoz C, Asselah T, et al. Reverse transcriptase- PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues [J].Pharmacogenet Genomics, 2007,17(9) : 731-742.
  • 10Thum T, Borlak J. Testosterone, eytochrome P450, and cardiac hypertrophy[J]. FASEB J,2002,16(12) :1537-1549.

二级参考文献30

共引文献27

同被引文献63

引证文献6

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部